RATIO ANALYSIS
You can view the ratio analysis for the last 5 years.
Genomic Valley Biotech Ltd.
May 07
BSE
59.50
( -0.50 -0.83%)
Volume2
Prev. Close
60.00
Open Price
59.50
Today's Low / High
59.50
59.50
Bid. Price (Qty.)0.00 (0)
Offer Price (Qty.)
0.00 (0)
52 Wk Low / High
28.36
108.15
Genomic Valley Biotech Ltd.is not traded in NSE
Reported EPS (₹ Cr.)
Net Profit Margin (%)
Book Value (₹ Cr.)
Return on Networth (%)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | | |
| PER SHARE RATIOS | | | | | |
| | | | | | |
| Basic EPS (Rs.) | 0.05 | 2.12 | -0.03 | -1.83 | 0.94 |
| Diluted EPS (Rs.) | 0.05 | 2.12 | -0.03 | -1.83 | 0.94 |
| Cash EPS (Rs.) | 0.05 | 2.15 | 0.24 | -1.21 | 1.52 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 11.60 | 11.55 | 9.42 | 14.69 | 16.52 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 11.60 | 11.55 | 9.42 | 14.69 | 16.52 |
| Revenue From Operations / Share (Rs.) | 0.54 | 8.91 | 0.23 | 0.68 | 2.77 |
| PBDIT / Share (Rs.) | 0.05 | 3.02 | -0.96 | -0.44 | 1.85 |
| PBIT / Share (Rs.) | 0.04 | 2.99 | -1.24 | -1.06 | 1.26 |
| PBT / Share (Rs.) | 0.04 | 2.12 | -1.38 | -1.64 | 0.67 |
| Net Profit / Share (Rs.) | 0.04 | 2.12 | -0.03 | -1.83 | 0.93 |
| | | | | | |
| PROFITABILITY RATIOS | | | | | |
| | | | | | |
| PBDIT Margin (%) | 9.83 | 33.83 | -416.43 | -64.94 | 66.64 |
| PBIT Margin (%) | 9.17 | 33.54 | -535.97 | -155.88 | 45.55 |
| PBT Margin (%) | 9.17 | 23.83 | -596.37 | -241.16 | 24.30 |
| Net Profit Margin (%) | 9.19 | 23.81 | -13.23 | -268.67 | 33.78 |
| Return on Networth / Equity (%) | 0.42 | 18.38 | -0.32 | -12.45 | 5.66 |
| Return on Capital Employeed (%) | 0.42 | 25.89 | -10.55 | -4.80 | 5.32 |
| Return On Assets (%) | 0.35 | 14.66 | -0.24 | -7.33 | 3.57 |
| Long Term Debt / Equity (X) | 0.00 | 0.00 | 0.00 | 0.34 | 0.29 |
| Total Debt / Equity (X) | 0.16 | 0.17 | 0.00 | 0.34 | 0.29 |
| Asset Turnover Ratio (%) | 0.03 | 0.66 | 0.01 | 0.02 | 0.11 |
| | | | | | |
| LIQUIDITY RATIOS | | | | | |
| | | | | | |
| Current Ratio (X) | 3.68 | 2.88 | 5.31 | 0.18 | 0.52 |
| Quick Ratio (X) | 3.68 | 2.88 | 5.31 | 0.18 | 0.36 |
| Inventory Turnover Ratio (X) | 0.00 | 0.00 | 0.00 | 0.08 | 0.07 |
| | | | | | |
| COVERAGE RATIOS | | | | | |
| | | | | | |
| Interest Coverage Ratio (%) | 0.00 | 0.00 | -6.89 | -0.76 | 3.14 |
| Interest Coverage Ratio (Post Tax) (%) | 0.00 | 0.00 | -9.05 | -2.15 | 2.59 |
| | | | | | |
| VALUATION RATIOS | | | | | |
| | | | | | |
| Enterprise Value (Cr.) | 11.20 | 7.21 | 7.56 | 8.74 | 4.09 |
| EV / Net Operating Revenue (X) | 67.84 | 2.65 | 107.10 | 42.02 | 4.83 |
| EV / EBITDA (X) | 689.51 | 7.83 | -25.72 | -64.70 | 7.24 |
| MarketCap / Net Operating Revenue (X) | 64.23 | 2.44 | 107.14 | 34.64 | 3.12 |
| Price / BV (X) | 2.99 | 1.88 | 2.63 | 1.61 | 0.52 |
| Price / Net Operating Revenue (X) | 64.28 | 2.44 | 107.14 | 34.65 | 3.13 |
| EarningsYield | 0.00 | 0.09 | 0.00 | -0.07 | 0.10 |
| Months | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR |
| FaceValue | 10.00 |
| | |
| PER SHARE RATIOS | |
| Basic EPS (Rs.) | 0.05 |
| Diluted EPS (Rs.) | 0.05 |
| Cash EPS (Rs.) | 0.05 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 11.60 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 11.60 |
| Revenue From Operations / Share (Rs.) | 0.54 |
| PBDIT / Share (Rs.) | 0.05 |
| PBIT / Share (Rs.) | 0.04 |
| PBT / Share (Rs.) | 0.04 |
| Net Profit / Share (Rs.) | 0.04 |
| PROFITABILITY RATIOS | |
| PBDIT Margin (%) | 9.83 |
| PBIT Margin (%) | 9.17 |
| PBT Margin (%) | 9.17 |
| Net Profit Margin (%) | 9.19 |
| Return on Networth / Equity (%) | 0.42 |
| Return on Capital Employeed (%) | 0.42 |
| Return On Assets (%) | 0.35 |
| Long Term Debt / Equity (X) | 0.00 |
| Total Debt / Equity (X) | 0.16 |
| Asset Turnover Ratio (%) | 0.03 |
| LIQUIDITY RATIOS | |
| Current Ratio (X) | 3.68 |
| Quick Ratio (X) | 3.68 |
| Inventory Turnover Ratio (X) | 0.00 |
| COVERAGE RATIOS | |
| Interest Coverage Ratio (%) | 0.00 |
| Interest Coverage Ratio (Post Tax) (%) | 0.00 |
| VALUATION RATIOS | |
| Enterprise Value (Cr.) | 11.20 |
| EV / Net Operating Revenue (X) | 67.84 |
| EV / EBITDA (X) | 689.51 |
| MarketCap / Net Operating Revenue (X) | 64.23 |
| Price / BV (X) | 2.99 |
| Price / Net Operating Revenue (X) | 64.28 |
| EarningsYield | 0.00 |